Profound Medical
Mississauga
About Profound Medical
Profound Medical team is committed to creating the powerful combination of real-time MR guidance as the imaging platform and ultrasound as the energy source for delivering non-invasive ablative tools to clinicians. These key technology pillars, linked with intelligent software and robotics, have the potential to fulfill unmet needs of patients and clinicians in many anatomies and disease states, including prostate cancer, uterine fibroids, and bone metastases. Our mission is to profoundly change the standard of care by creating a tomorrow where clinicians can confidently ablate tissue with precision; a tomorrow where patients have access to safe and effective treatment options, so they can quickly return to their daily lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $332.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: tsx:PRN
- Website: profoundmedical.com
- Phone: (647)476-1350
Industries & Categories
Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/profound-medical-89836 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.